In Vitro Metabolism and Stability of the Actinide Chelating Agent 3,4,3-LI(1,2-HOPO)

The hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO) is currently under development for radionuclide chelation therapy. The preclinical characterization of this highly promising ligand comprised the evaluation of its in vitro properties, including microsomal, plasma, and gastrointestinal fluid stabilit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pharm Sci
Hlavní autoři: Choi, Taylor A., Furimsky, Anna M., Swezey, Robert, Bunin, Deborah I., Byrge, Patricia, Iyer, Lalitha V., Chang, Polly Y., Abergel, Rebecca J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4390475/
https://ncbi.nlm.nih.gov/pubmed/25727482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.24394
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky